Cargando…
Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case
Although surgery represents the treatment of choice for the majority of basal cell carcinomas, different therapies are required to treat the advanced ones. Vismodegib and sonidegib are the two oral Smoothened (Smo) inhibitors approved for the treatment of advanced basal cell carcinoma. Clinical dete...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163916/ https://www.ncbi.nlm.nih.gov/pubmed/33856641 http://dx.doi.org/10.1007/s13555-021-00533-9 |
_version_ | 1783701005066567680 |
---|---|
author | Villani, Alessia Fabbrocini, Gabriella Costa, Claudia Scalvenzi, Massimiliano |
author_facet | Villani, Alessia Fabbrocini, Gabriella Costa, Claudia Scalvenzi, Massimiliano |
author_sort | Villani, Alessia |
collection | PubMed |
description | Although surgery represents the treatment of choice for the majority of basal cell carcinomas, different therapies are required to treat the advanced ones. Vismodegib and sonidegib are the two oral Smoothened (Smo) inhibitors approved for the treatment of advanced basal cell carcinoma. Clinical detection of subclinical basal cell carcinoma during and after vismodegib treatment could be difficult, requiring the use of dermoscopy and reflectance confocal microscopy as noninvasive diagnostic methods. We report the case of a 62-year-old woman with a locally advanced basal cell carcinoma successfully treated with vismodegib in which dermoscopy and reflectance confocal microscopy showed their superiority in detecting subclinical recurrent basal cell carcinoma developed on scar tissue after complete regression of the tumor. |
format | Online Article Text |
id | pubmed-8163916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-81639162021-06-17 Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case Villani, Alessia Fabbrocini, Gabriella Costa, Claudia Scalvenzi, Massimiliano Dermatol Ther (Heidelb) Case Report Although surgery represents the treatment of choice for the majority of basal cell carcinomas, different therapies are required to treat the advanced ones. Vismodegib and sonidegib are the two oral Smoothened (Smo) inhibitors approved for the treatment of advanced basal cell carcinoma. Clinical detection of subclinical basal cell carcinoma during and after vismodegib treatment could be difficult, requiring the use of dermoscopy and reflectance confocal microscopy as noninvasive diagnostic methods. We report the case of a 62-year-old woman with a locally advanced basal cell carcinoma successfully treated with vismodegib in which dermoscopy and reflectance confocal microscopy showed their superiority in detecting subclinical recurrent basal cell carcinoma developed on scar tissue after complete regression of the tumor. Springer Healthcare 2021-04-15 /pmc/articles/PMC8163916/ /pubmed/33856641 http://dx.doi.org/10.1007/s13555-021-00533-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Case Report Villani, Alessia Fabbrocini, Gabriella Costa, Claudia Scalvenzi, Massimiliano Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case |
title | Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case |
title_full | Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case |
title_fullStr | Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case |
title_full_unstemmed | Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case |
title_short | Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case |
title_sort | reflectance confocal microscopy identification of subclinical basal cell carcinoma after vismodegib treatment: report of a case |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163916/ https://www.ncbi.nlm.nih.gov/pubmed/33856641 http://dx.doi.org/10.1007/s13555-021-00533-9 |
work_keys_str_mv | AT villanialessia reflectanceconfocalmicroscopyidentificationofsubclinicalbasalcellcarcinomaaftervismodegibtreatmentreportofacase AT fabbrocinigabriella reflectanceconfocalmicroscopyidentificationofsubclinicalbasalcellcarcinomaaftervismodegibtreatmentreportofacase AT costaclaudia reflectanceconfocalmicroscopyidentificationofsubclinicalbasalcellcarcinomaaftervismodegibtreatmentreportofacase AT scalvenzimassimiliano reflectanceconfocalmicroscopyidentificationofsubclinicalbasalcellcarcinomaaftervismodegibtreatmentreportofacase |